LGMN and breast carcinoma: In addition to caspase, linkers that can respond to legumain, a biomarker overexpressed in several cancers such as breast cancer, gastric cancer, colorectal cancer, have been developed for PET imaging of legumain activity and diagnosis of legumain‐related diseases.